Letter to Restore Asthma As a Co-Morbidity for COVID-19 Vaccines
February 12, 2021 February 12, 2021 Governor Charles Baker State House, Room 280 24 Beacon Street Boston, MA 02144 Secretary Marylou Sudders Executive OfFice oF Health and Human Services 1 Ashburton Place, 11th Floor Boston, MA 02108 Dear Governor Baker and Secretary Sudders: We write today to urge you to restore moderate to severe asthma to the list oF illnesses which constitute a co-morbidity For COVID-19 vaccine distribution and administration purposes. The CDC currently lists moderate to severe asthma as an illness that could present an increased risk For “severe illness From the virus that causes COVID-19” (https://www.cdc.gov/coronavirus/2019-ncov/need- extra-precautions/people-with-medical-conditions.html). In 2019, Springfield was described as the nation’s number one asthma capitol by the Asthma and Allergy Foundation of America (https://www.aafa.org/asthma-capitals-top-100-cities-ranking/). We believe the erroneous removal of moderate to severe asthma From the Massachusetts list oF eligible co-morbidities for phase two of the vaccination distribution must be revisited, especially when it is such a common experience among residents in the Commonwealth. Our own Massachusetts Department of Public Health has been engaged on multiple Fronts with combatting asthma in the Commonwealth, including community-based and medical interventions. Prioritizing asthma as a co-morbidity is a public health and racial equity issue. According to the MDPH, the “prevalence of current asthma in Massachusetts was higher among Black, Non-Hispanic adults than White, non-Hispanic adults.” (https://www.mass.gov/service-details/statistics-about- asthma). We recogniZe the importance oF addressing the disproportionate impact of moderate to severe asthma on black and brown communities in the Commonwealth and request that it be prioritized For vaccine distribution as a COVID-19 co-morbidity.
[Show full text]